Sight Sciences holder plans sale of 12,014 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, trading under symbol SGHT, has a filing stating that shareholder Jeremy Hayden plans to sell up to 12,014 shares of common stock through Fidelity Brokerage Services LLC on or after August 17, 2026 on NASDAQ, with an indicated aggregate market value of $97,841.48.
The disclosure also lists prior common stock sales by Hayden during July and August 2026, and notes that some shares derive from restricted stock vesting granted as compensation on January 1, 2024 and June 30, 2026.
Key Figures
Key Terms
Form 144 regulatory
restricted stock vesting financial
compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the SGHT Form 144 filing disclose about planned stock sales?
Who is the selling security holder in the SGHT Form 144 notice?
What prior SGHT stock sales by Jeremy Hayden are reported in the last three months?
What proceeds are shown for Jeremy Hayden’s recent SGHT stock sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.